ACCEL Lite: The Effects of Early Rhythm Control Therapy in Patients With AF

Oct 20, 2020   |  Alison Bailey, MD, FACC; Freek W. A. Verheugt, MD, FACC; Paulus F Kirchhof

Podcast

Font Size
A
A
A

In this interview, Freek Verheugt and Paulus Kirchhof discuss EAST-AFNET 4: Effects of Early Rhythm Control Therapy in Patients with Atrial Fibrillation from ESC Congress 2020. The results of EAST-AFNET 4 could redefine the role of rhythm control therapy for improved outcomes in patients with early atrial fibrillation.

Like what you hear? ACCEL Subscribers enjoy 20+ insider interviews like these every month, with CME/MOC credit and other exclusive benefits. Subscribe today for more, and check out what's new at www.acc.org/ACCEL

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Clinical Topics: Arrhythmias and Clinical EP, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias

Keywords: Arrhythmias, Cardiac, ACCELLite, Electrophysiology, ESC Congress, ESC20, Atrial Fibrillation


< Back to Listings